HOOK Live signals | Maximize Profits with Getagraph.com

SELL 104329 min ago

@ $0.697

Issued: 14 Feb 2024 @ 09:37

Return: 28.13%

Previous signal: Feb 12 - 14:32

Previous signal: Buy

Return: 4.84 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform...

Stats
Today's Volume	2.86M
Average Volume	744 151
Market Cap	86.25M
EPS	$0 ( 2024-03-20 )
Next earnings date	( $-0.120 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.040
ATR14	$0.00600 (0.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Orlinger Klaus	Buy	367 300	Stock Option (Right to Buy)
2024-04-15	Aldag Jorn	Buy	971 400	Stock Option (Right to Buy)
2024-04-15	Winderlich Mark	Buy	250 000	Stock Option (Right to Buy)
2024-04-15	Winderlich Mark	Buy	50 000	Stock Option (Right to Buy)
2024-04-15	Kandera Reinhard	Buy	406 200	Stock Option (Right to Buy)

INSIDER POWER
98.82
Last 94 transactions
Buy: 7 455 375 \| Sell: 565 370

Volume Correlation

Long: -0.24 (neutral)

Short: -0.96 (very strong negative)

Signal:(41.772) Neutral

HOOKIPA Pharma Inc Correlation

10 Most Positive Correlations
TCRT	0.916
VSTA	0.914
JNCE	0.904
INFI	0.903
MPAA	0.903
VCSA	0.902
POWW	0.899
VIRX	0.899
GRAY	0.897
TOI	0.896

10 Most Negative Correlations
IMMR	-0.897
PBFS	-0.892
BNIXU	-0.887
ISIG	-0.875
WEN	-0.873
CCRC	-0.872
MGI	-0.869
SEDG	-0.864
IBEX	-0.862
MSON	-0.859

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HOOKIPA Pharma Inc Correlation - Currency/Commodity

0.11
( neutral )

0.10
( neutral )

0.00
( neutral )

0.49
( neutral )

HOOKIPA Pharma Inc Financials

Annual	2023
Revenue:	$20.13M
Gross Profit:	$16.58M (82.35 %)
EPS:	$-0.860

FY	2023
Revenue:	$20.13M
Gross Profit:	$16.58M (82.35 %)
EPS:	$-0.860

FY	2022
Revenue:	$14.25M
Gross Profit:	$10.65M (74.72 %)
EPS:	$-0.990

FY	2021
Revenue:	$18.45M
Gross Profit:	$18.45M (100.00 %)
EPS:	$-2.79

Financial Reports:

No articles found.

HOOKIPA Pharma Inc

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.